University of Maryland Greenebaum Cancer Center [clinicaltrials_resource:f797b15d20668342bc682395dacefa08]
David A. Van Echo, MD [clinicaltrials_resource:14202a60ffd60cc2b744cfcf6b7a2486]Abraham Kroon, MD, PhD [clinicaltrials_resource:1526800ff7e961797416facd992a3b32]Aaron P. Rapoport, MD [clinicaltrials_resource:1d578eb8ad698ed9b9ceb5775fd2123b]H. Richard Alexander [clinicaltrials_resource:35e02709623a359f81189ae2bb6d4e37]Katherine Tkaczuk, MD [clinicaltrials_resource:39c0cba11ffdf08557e6faf176a49a34]Mark J. Krasna, MD [clinicaltrials_resource:3a9a53045a200ce316c8f75cd86094d9]Dan Zandberg, MD [clinicaltrials_resource:4136086e102c8fb618ee1c7bcb5843a3]Katherine Tkaczuk, MD [clinicaltrials_resource:458c460c48a044bd6776843eb8357e0c]Dan Zandberg, MD [clinicaltrials_resource:45d71584f81bd439e76fe60f511023e6]Martin Edelman [clinicaltrials_resource:48a81e8e746ff9fc00c20bdc3293088d]Nancy A. Dawson, MD [clinicaltrials_resource:50918dcc92be6229a5f0131e40b747c3]Ivana Gojo [clinicaltrials_resource:591011ead2a69bc025221d5898f1efad]Ashraf Z Badros, M.B.,Ch.B [clinicaltrials_resource:59f24a60d41153de4aff2901bcfd846a]Dan Zandberg, MD [clinicaltrials_resource:5c941f322321448b09304a67930e24ee]Ashraf Z Badros, M.B.,Ch.B [clinicaltrials_resource:5d2e797eaf8968839e3cfc959ce8bbc3]Maria R. Baer, MD [clinicaltrials_resource:60b2ea0e47164660686867cd351c2e03]Mohan Suntharalingam, MD [clinicaltrials_resource:6b810f355b4cacb821af8d9d9fc2f9bc]Dan Zandberg, MD [clinicaltrials_resource:75561b8cb6ae46786075bcebef1efb09]Ashraf Z Badros, M.B.,Ch.B [clinicaltrials_resource:799c4f33d1505b13f15c9bb5333bb362]Ashraf Z. Badros, MD [clinicaltrials_resource:86c8e9c56c4c1d2eb6b3e599d5e2814c]Katherine Tkaczuk, MD [clinicaltrials_resource:8828dc8a264b61cfb07f4c36a138eef9]Sandra E. Brooks, MD [clinicaltrials_resource:88307465951706e514ea1bc9185f8516]Diane Keegan Wells, RN, MSN, CPNP [clinicaltrials_resource:88996595ecb0359d595e562045a40bec]Dan Zandberg, MD [clinicaltrials_resource:8b8cada79e29c68c61861454b21a677d]Michael C. Garofalo, MD [clinicaltrials_resource:91034c9283eec9a14181ba5d21820005]Dan Zandberg, MD [clinicaltrials_resource:9269a9197f275ba4db077f300161f7b7]Dan Zandberg, MD [clinicaltrials_resource:932251dff9308ae05b68a41b9f588963]Edward Sausville, MD [clinicaltrials_resource:94852e233496295564175cc691c5b009]Meyer Heyman [clinicaltrials_resource:980d3639bca198760b8503439614695a]Joshua R. Sonett, MD [clinicaltrials_resource:9a5762d7d05b5e789abf359fcd0ba713]Aaron Rapoport, M.D. [clinicaltrials_resource:9cc2adc48d219d6f52208abbab180e3f]Ashraf Z Badros, M.B.,Ch.B [clinicaltrials_resource:a04670bf2ad13d4547578ab45813240e]Aaron P. Rapoport, MD [clinicaltrials_resource:a1bc4267cde7c80f0329dbfa12854184]Ashraf Z Badros, M.B.,Ch.B [clinicaltrials_resource:a2fc7d726b12d900e0b6d9ca40b7d414]Douglas Ross [clinicaltrials_resource:a8eae426986c9a1e4df4fc47ca0f6abc]Ashraf Badros [clinicaltrials_resource:b7b274b40bc7111882750ee505e8728e]Edward A. Sausville, MD, PhD [clinicaltrials_resource:ccedad6965062a0c9c6acd2678f24646]Edward A. Sausville, MD, PhD [clinicaltrials_resource:d0180280977d6b0756c4269bb92d5573]Arif Hussain, MD [clinicaltrials_resource:da8d153997e312e2bd0e814fc1256d17]Ashraf Z Badros, M.B.,Ch.B [clinicaltrials_resource:dde47b16ea2e741c641e63a4ce61881b]
affiliation [clinicaltrials_vocabulary:affiliation]
R115777 in Treating Patients With Refractory or Recurrent Acute Leukemia or Chronic Myelogenous Leukemia [clinicaltrials:NCT00004009]Vaccine Therapy in Treating Patients With Recurrent Prostate Cancer [clinicaltrials:NCT00030602]Stem Cell Transplant, Chemotherapy, and Biological Therapy in Treating Patients With High-Risk or Refractory Multiple Myeloma [clinicaltrials:NCT00499577]clinicaltrials:NCT00729807
collaborator [clinicaltrials_vocabulary:collaborator]
Peripheral Stem Cell Transplantation Plus Combination Chemotherapy in Treating Patients With Multiple Myeloma [clinicaltrials:NCT00003399]Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Prostate Cancer [clinicaltrials:NCT00003400]Peripheral Stem Cell Transplantation Plus Combination Chemotherapy in Treating Patients With Multiple Myeloma [clinicaltrials:NCT00003401]R115777 in Treating Patients With Refractory or Recurrent Acute Leukemia or Chronic Myelogenous Leukemia [clinicaltrials:NCT00004009]Chemotherapy Plus Donor White Blood Cell Infusion in Treating Patients With Relapsed Hematologic Cancer Following Donor Peripheral Stem Cell Transplantation [clinicaltrials:NCT00005946]Mycophenolate Mofetil, Tacrolimus, Daclizumab, and Donor Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer [clinicaltrials:NCT00006350]Vaccine Therapy in Treating Patients With Recurrent Prostate Cancer [clinicaltrials:NCT00030602]Stem Cell Transplant, Chemotherapy, and Biological Therapy in Treating Patients With High-Risk or Refractory Multiple Myeloma [clinicaltrials:NCT00499577]clinicaltrials:NCT00729807
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
University of Maryland Greenebaum Cancer Center [clinicaltrials_resource:f797b15d20668342bc682395dacefa08]
Bio2RDF identifier
f797b15d20668342bc682395dacefa08
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:f797b15d20668342bc682395dacefa08
organization [clinicaltrials_vocabulary:organization]
identifier
clinicaltrials_resource:f797b15d20668342bc682395dacefa08
title
University of Maryland Greenebaum Cancer Center
@en
type
label
University of Maryland Greeneb ...... 7b15d20668342bc682395dacefa08]
@en